• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ImmuCell Corp

+ Add to Watchlist


4.9700 USD 0.0365 0.74%

As of 17:20:00 ET on 09/30/2014.

Snapshot for ImmuCell Corp (ICCC)

Open: 4.9300 Day's Range: 4.9300 - 4.9700 Volume: 600
Previous Close: 4.9335 52wk Range: 3.3000 - 5.6799 1-Yr Rtn: +5.07%

Stock Chart for ICCC

No chart data available.
  • ICCC:US 4.9700
  • 1D
  • 1M
  • 1Y
Interactive ICCC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ICCC

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.1344
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 15.04
Shares Outstanding (M) 3.03
30 Day Average Volume 4,909
Price/Book (mrq) 1.6019
Price/Sale (ttm) 2.3426
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ICCC

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ICCC

ImmuCell Corporation is a biotechnology company which develops and manufactures milk-derived passive antibody products. The Company's products prevent and/or treat gastrointestinal infections in humans and animals. ImmuCell also, through joint ventures, entered into a UK distribution agreement to market Crypto-Scan, a drinking-water test, and is also manufacturing bovine lactoferrin.

Michael F BrighamPresident/CEO/Treasurer/SecyJoseph H CrabbVP/Chief Scientific Officer
Bobbi Jo Brockmann "Kunde"Director:Sales & MarketingJohn W ZinckgrafDirector:Product Development
More Company Profile & Key Executives for ICCC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil